1999 Fiscal Year Final Research Report Summary
Gene Therapy for Experimental Gliomas Using Chemosensitivity Genes
| Project/Area Number |
09671425
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Cerebral neurosurgery
|
|---|
| Research Institution | OKAYAMA UNIVERSITY |
|---|
Principal Investigator |
TAMIYA Takashi Okayama University Medical School Hospital, Lecture, 医学部・附属病院, 講師 (50252953)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
ONO Yasuhiro Okayama University Medical School, Assistant, 医学部, 助手 (40294409)
MATSUMOTO Kengo Okayama University Medical School, Assistant Professor, 医学部, 助教授 (10190521)
|
|---|
| Project Period (FY) |
1997 – 1999
|
| Keywords | adenovirus vector / gene therapy / brain tumors / cytosine deaminase / 5-fluorocytosine / 5-fluoruoracil / chemosensitivity gene / uracil phosphoribosyltransferase |
|---|
| Research Abstract |
Transduction of the cytosine deaminase (CD) gene into tumor cells followed by administration of 5-fluorocytosine (5-FC), called 5-FC/CD gene therapy, was created as suicide gene therapy for various cancers. The uracil phosphoribosyltransferase (UPRT) gene, which is absent from mammalian cells, directly converts 5-fluoruoracil (5-FU) to 5-fluoruorridine 5'-monophosphate. We evaluated whether the coexpression of CD and UPRT genes could generate a synergistic antitumor effect on experimental brain tumors. In vitro study showed that UPRT-transduced 9L cells mediated by an adenovirus were 16 times more sensitive to 5-FU, and CD + UPRT-transduced cells were 6,000 times more sensitive to 5-FC than parent cells, indicating that the acquisition of CD and UPRT further increased the 5-FC sensitivity of 9L cells compared to that of CD alone. In a rat brain tumor model, a decreased amount of vectors of CD and UPRT were inoculated into the tumors to detect any additional effect of UPRT. CD and UPRT coexpression followed by 5-FC administration showed an antitumor effect detected by sequential magnetic resonance imaging. This therapy significantly prolonged animal survival. These results suggest that 5-FC/CD+UPRT gene therapy can enhance the antitumor effect of 5-FC/CD gene therapy. Consequently, this approach might be a more feasible modality for the treatment of malignant brain tumors.
|
